Chemical Structure (Zur00 0003 01)
Zurzuvae Capsule
Product Images NDC 64406-030
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zurzuvae (NDC 64406-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biogen Ma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Zur00 0003 02)
Figure 2 (Zur00 0003 03)
Figure 3 (Zur00 0003 04)
Principal Display Panel (30 mg Bottle Carton)
Principal Display Panel (25 mg Blister Pack Carton)
The text provides limited information about a medication called ZURZUVAE™ (zuranolone) capsules. It comes in a pack with 28 capsules, with each capsule containing 25 mg of zuranolone. The medication is meant for oral use. There is a mention of a 14-day blister, but further details are not provided. The text also instructs to dispense a daily dose of 50 mg and advises referring to the Medication Guide for more information. The provided text does not provide a complete description, and additional details are not available.*
Principal Display Panel (20 mg Bottle Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
